The Director, Value & Evidence, Oncology Pipeline Lead will support the strategic goals of the Oncology Business Unit (BU) by driving optimal clinical development strategy and access evidence generation focused on maximizing patient access for currently in development oncology products. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust access evidence development relevant to achieve optimal patient access by demonstrating the value of our oncology pipeline. The Director, Value & Evidence, Oncology Pipeline Lead will be responsible for developing and executing against the global access evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables. ROLE RESPONSIBILITIES • Lead the development of the access evidence generation strategy to support the value of Pfizer’s oncology pipeline assets, in close partnership with the cross-functional matrix team. • Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the access evidence strategy to support global market access needs at launch and through lifecycle. • Lead the timely development of early launch deliverables including early global value dossiers, value and evidence strategy, integrated evidence plan, systematic literature reviews, early economic models, predictive analytics for value and evidence, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries. • Lead the design and execution of global HEOR studies (e.g., network meta-analyses, real-world evidence) from concept through publication. • Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. • Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers. • Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs. • Partner with other GAV cross functional colleagues to ensure strategic alignment and successful/timely execution of projects. • Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.